본문으로 건너뛰기
← 뒤로

Exoscopic Microsurgery: A Change of Paradigm in Brain Tumor Surgery? Comparison with Standard Operative Microscope.

Brain sciences 2023 Vol.13(7) 🌐 cited 3 🔓 OA Glioma Diagnosis and Treatment
📈 연도별 인용 (2023–2025) · 합계 3
OpenAlex 토픽 · Glioma Diagnosis and Treatment Anatomy and Medical Technology Meningioma and schwannoma management

Di Cristofori A, Graziano F, Rui CB, Rebora P, Di Caro D, Chiarello G, Stefanoni G, Julita C, Florio S, Ferlito D, Basso G, Citerio G, Remida P, Carrabba G, Giussani C

관련 도메인

📝 환자 설명용 한 줄

[BACKGROUND] The exoscope is a high-definition telescope recently introduced in neurosurgery.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Andrea Di Cristofori, Francesca Graziano, et al. (2023). Exoscopic Microsurgery: A Change of Paradigm in Brain Tumor Surgery? Comparison with Standard Operative Microscope.. Brain sciences, 13(7). https://doi.org/10.3390/brainsci13071035
MLA Andrea Di Cristofori, et al.. "Exoscopic Microsurgery: A Change of Paradigm in Brain Tumor Surgery? Comparison with Standard Operative Microscope.." Brain sciences, vol. 13, no. 7, 2023.
PMID 37508967

Abstract

[BACKGROUND] The exoscope is a high-definition telescope recently introduced in neurosurgery. In the past few years, several reports have described the advantages and disadvantages of such technology. No studies have compared results of surgery with standard microscope and exoscope in patients with glioblastoma multiforme (GBM).

[METHODS] Our retrospective study encompassed 177 patients operated on for GBM (WHO 2021) between February 2017 and August 2022. A total of 144 patients were operated on with a microscope only and the others with a 3D4K exoscope only. All clinical and radiological data were collected. Progression-free survival (PFS) and overall survival (OS) have been estimated in the two groups and compared by the Cox model adjusting for potential confounders (e.g., sex, age, Karnofsky performance status, gross total resection, MGMT methylated promoter, and operator's experience).

[RESULTS] IDH was mutated in 9 (5.2%) patients and MGMT was methylated in 76 (44.4%). Overall, 122 patients received a gross total resection, 14 patients received a subtotal resection, and 41 patients received a partial resection. During follow-up, 139 (73.5%) patients experienced tumor recurrence and 18.7% of them received a second surgery. After truncation to 12 months, the median PFS for patients operated on with the microscope was 8.82 months, while for patients operated on with the exoscope it was >12 months. Instead, the OS was comparable in the two groups. The multivariable Cox model showed that the use of microscope compared to the exoscope was associated with lower progression-free survival (hazard ratio = 3.55, 95%CI = 1.66-7.56, = 0.001).

[CONCLUSIONS] The exoscope has proven efficacy in terms of surgical resection, which was not different to that of the microscope. Furthermore, patients operated on with the exoscope had a longer PFS. A comparable OS was observed between microscope and exoscope, but further prospective studies with longer follow-up are needed.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 microsurgery 미세수술 dict 1
약물 [BACKGROUND] The scispacy 1
약물 [RESULTS] IDH scispacy 1
약물 [CONCLUSIONS] The scispacy 1
질환 Tumor C0027651
Neoplasms
scispacy 1
질환 glioblastoma multiforme C1621958
Glioblastoma Multiforme
scispacy 1
질환 IDH C2697642
IDH1 wt Allele
scispacy 1
질환 Brain Tumor scispacy 1
질환 GBM → glioblastoma multiforme scispacy 1
기타 MGMT scispacy 1

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

같은 제1저자의 인용 많은 논문 (1)

관련 논문